Drug Profile


Alternative Names: Ganaton; HSR 803; Itax

Latest Information Update: 13 Feb 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Abbott Japan
  • Developer Abbott Japan; AbbVie; Astellas Pharma; Axcan Pharma
  • Class Antiulcers; Benzamides; Benzyl compounds; Gastrokinetics; Small molecules
  • Mechanism of Action Dopamine D2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Gastritis; Gastrointestinal disorders
  • Discontinued Diabetic gastroparesis; Non-ulcer dyspepsia; Postoperative ileus

Most Recent Events

  • 13 Feb 2017 CTP push 281683 - Trial completion info already updated; Minor updates done in KDM
  • 03 Feb 2014 Aptalis has been acquired by Forest Laboratories
  • 02 Jan 2013 Abbott separates its pharmaceuticals business to new company called AbbVie
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top